摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-([4,6-bis(1,1-dimethylethyl)-5-hydroxy-2-pyrimidinyl]amino)-4-thiazolecarboxylic acid | 148806-41-1

中文名称
——
中文别名
——
英文名称
2-([4,6-bis(1,1-dimethylethyl)-5-hydroxy-2-pyrimidinyl]amino)-4-thiazolecarboxylic acid
英文别名
2-[[4,6-Bis(1,1-dimethylethyl)-5-hydroxy-2-pyrimidinyl]amino]-4-thiazolecarboxylic acid;2-[(4,6-ditert-butyl-5-hydroxypyrimidin-2-yl)amino]-1,3-thiazole-4-carboxylic acid
2-([4,6-bis(1,1-dimethylethyl)-5-hydroxy-2-pyrimidinyl]amino)-4-thiazolecarboxylic acid化学式
CAS
148806-41-1
化学式
C16H22N4O3S
mdl
——
分子量
350.442
InChiKey
MCVRQQYNLGRQQI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    24
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    137
  • 氢给体数:
    3
  • 氢受体数:
    8

反应信息

点击查看最新优质反应信息

文献信息

  • 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as
    申请人:Warner-Lambert Company
    公开号:US05220025A1
    公开(公告)日:1993-06-15
    The present invention is novel compounds which are 2-substituted amino-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines and pharmaceutically acceptable acid addition or base salts thereof, pharmaceutical compositions and methods of use therefor. The invention compounds are described as having activity as inhibitors of 5-lipoxygenase and/or cyclooxygenase providing treatment of conditions advantageously affected by such inhibition including inflammation, arthritis, pain, fever and the like. Thus, the present invention is also a pharmaceutical composition or method of manufacturing a pharmaceutical composition for the use of treating the noted conditions.
    本发明涉及一种新型化合物,即2-取代基-4,6-叔丁基-5-羟基-1,3-嘧啶及其药学上可接受的酸加合物或碱盐,以及其制备方法和药物组合物。该发明化合物被描述为5-脂氧合酶和/或环氧合酶的抑制剂,可用于治疗由此类抑制剂有利影响的疾病,包括炎症、关节炎、疼痛、发热等。因此,本发明还涉及用于治疗上述疾病的药物组合物或药物组合物的制备方法。
  • 2-substituted amino-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines as
    申请人:Warner-Lambert Company
    公开号:US05284949A1
    公开(公告)日:1994-02-08
    The present invention is novel compounds which are 2-substituted amino-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines and pharmaceutically acceptable acid addition or base salts thereof, pharmaceutical compositions and methods of use therefor. The invention compounds are described as having activity as inhibitors of 5-lipoxygenase and/or cyclooxygenase providing treatment of conditions advantageously affected by such inhibition including inflammation, arthritis, pain, fever and the like. Thus, the present invention is also a pharmaceutical composition or method of manufacturing a pharmaceutical composition for the use of treating the noted conditions.
    本发明涉及新型化合物,其为2-取代基-4,6-叔丁基-5-羟基-1,3-嘧啶及其药学上可接受的酸加合物或碱盐,以及其药物组合物和使用方法。本发明化合物被描述为5-脂氧合酶和/或环氧合酶抑制剂,可用于治疗因此类抑制而受益的情况,包括炎症、关节炎、疼痛、发热等。因此,本发明还涉及一种药物组合物或制造药物组合物的方法,用于治疗上述疾病。
  • US5196431A
    申请人:——
    公开号:US5196431A
    公开(公告)日:1993-03-23
  • US5220025A
    申请人:——
    公开号:US5220025A
    公开(公告)日:1993-06-15
  • US5284949A
    申请人:——
    公开号:US5284949A
    公开(公告)日:1994-02-08
查看更多